Original paper

Generalizability of glucagon‐like peptide‐1 receptor agonist cardiovascular outcome trials to the overall type 2 diabetes population in the United States

Volume: 21, Issue: 6, Pages: 1299 - 1304
Published: Mar 12, 2019
Abstract
Aim To examine the generalizability of results from glucagon‐like peptide‐1 receptor agonist (GLP‐1 RA) cardiovascular outcome trials (CVOTs) in the US type 2 diabetes (T2D) population. Materials and methods Patients enrolled or eligible for inclusion in four CVOTs (EXSCEL, LEADER, REWIND, and SUSTAIN‐6) were examined in reference to a retrospective clinical database weighted to match the age and sex distribution of the US adult T2D population....
Paper Details
Title
Generalizability of glucagon‐like peptide‐1 receptor agonist cardiovascular outcome trials to the overall type 2 diabetes population in the United States
Published Date
Mar 12, 2019
Volume
21
Issue
6
Pages
1299 - 1304
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.